Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia

Clinical trial NCT02262143 · COMPLETED

Trial details

NCT number: NCT02262143
Sponsor: IlDong Pharmaceutical Co Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mixed Dyslipidemias

Start date: 2014-11-01
Primary completion: 2016-10-01
Enrollment: 362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.